InvestorsHub Logo

DewDiligence

08/30/16 5:20 PM

#203934 RE: DewDiligence #203923

RIGL closed +49% on the news in the post I’m replying to.

DewDiligence

09/15/16 4:47 PM

#204335 RE: DewDiligence #203923

RIGL cuts workforce 38%—(46 jobs)—to focus on Fostamatinib commercialization:

http://finance.yahoo.com/news/rigel-restructures-focus-fostamatinib-commercialization-113000757.html